CG Oncology, Inc.

CGON

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001991792

SEC filings (opens in a new tab)

In the last 90 days, CG Oncology, Inc. insiders filed 0 open-market purchases and 4 sales; 227 institutions reported holding it in 13F filings for Q2 2026, worth $6.66B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding CG Oncology, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of CGON: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	111	1	121	+11
Shares	43.3M	1.98M	52.2M	+10.9M (+26.4%)
Value	$1.37B	$62.4M	$1.96B	+$659.1M (+50.6%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held CG Oncology, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to CGON in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	3,570,927	$134.7M	0.00%
OrbiMed Advisors LLC	691,114	$26.1M	0.48%
Saturn V Capital Management LLC	520,119	$19.6M	7.01%
Schonfeld Strategic Advisors LLC	91,062	$3.44M	0.03%
Canada Pension Plan Investment Board	83,000	$3.13M	0.00%
Tudor Investment Corp Et Al	37,759	$1.42M	0.02%
Neo Ivy Capital Management	29,678	$1.12M	0.36%
Polar Asset Management Partners Inc.	25,800	$973.4K	0.02%
Dark Forest Capital Management LP	22,596	$852.5K	0.11%
Los Angeles Capital Management LLC	22,052	$832.0K	0.00%
SG Americas Securities, LLC	17,595	$664.0K	0.00%
HighVista Strategies LLC	15,734	$593.6K	0.20%
Susquehanna International Group, LLP	12,993	$490.2K	0.00%
Seven Eight Capital, LP	12,744	$480.8K	0.04%
Trexquant Investment LP	9,282	$350.2K	0.00%
ProShare Advisors LLC	8,962	$338.1K	0.00%
Crestline Management, LP	7,890	$297.7K	0.02%
Zurcher Kantonalbank (Zurich Cantonalbank)	6,399	$241.4K	0.00%
HSBC Holdings PLC	5,792	$221.9K	0.00%
Acadian Asset Management LLC	1,227	$46.0K	0.00%
GAMMA Investing LLC	106	$4.00K	0.00%
Sterling Capital Management LLC	92	$3.47K	0.00%
Bessemer Group Inc	35	$1.00K	0.00%
Parallel Advisors, LLC	17	$641	0.00%
AdvisorNet Financial, Inc	2	$75	0.00%
Capital Performance Advisors LLP	1	$38	0.00%

Sold out (15)

Institutions that held CG Oncology, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of CGON in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Walleye Capital LLC	211,006	$6.66M
T. Rowe Price Investment Management, Inc.	66,596	$2.10M
Renaissance Technologies LLC	43,200	$1.36M
Ghisallo Capital Management LLC	25,000	$789.3K
Verition Fund Management LLC	15,775	$498.0K
LMR Partners LLP	13,616	$429.9K
Millennium Management LLC	13,072	$412.7K
Landscape Capital Management, L.L.C.	9,588	$302.7K
Scientech Research LLC	8,803	$277.9K
Jump Financial, LLC	7,536	$237.9K
Point72 Asia (Singapore) Pte. Ltd.	1,209	$38.2K
Pacer Advisors, Inc.	290	$9.15K
Simplex Trading, LLC	264	$8.00K
Headlands Technologies LLC	143	$4.51K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	80	$2.52K

Not filed for Q3 2024 yet (1)

Institutions that held CG Oncology, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CGON in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	1,976,070	$62.4M